The Evolving Future of PCSK9 Inhibitors
Robert S. RosensonZena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: [email protected]Robert A. HegeleDepartment of Medicine and Robarts Research Institute, Schulich School of Medicine, Western University, London, Ontario, CanadaSergio FazioOregon Health & Science University, Knight Cardiovascular Institute, Center for Preventive Cardiology, Portland, OregonChristopher P. CannonCardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
2018en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 4Использованных источников: 0